Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Atul share price today

ATULDyes and pigmentsConsolidatedPrices to 12 Nov 2026Results to Sep 2026

Price, 200-day average and NIFTY 500

The price is 16.8% below its 200-day average and 93 points behind the NIFTY 500 over 5 years

12 Nov 2026₹5,208.00Over 5 years: Atul −40.1%, NIFTY 500 +52.6%
₹5,000₹12,500Nov 22Nov 24Nov 26

Price growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y−12.0%3Y−7.9%/yr5Y−9.7%/yr10Y+9.2%/yr

EPS and P/E

EPS ₹262.19, up 42% in a year; P/E 19.9

12 Nov 2026₹262.19 EPS
Mar 22
Jun 22
Sep 22
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Nov 26
₹0₹300

EPS growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+42.4%3Y+25.4%/yr5YToo short10YToo short

Revenue and margins

Revenue up on a year for 11 quarters in a row; operating margin 13.2%

Sep 2026 quarter₹1,877 crore+20.9% on ₹1,552 crore a year earlier · NPM 8.5%
Dec 21
Mar 22
Jun 22
Sep 22
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
0₹2,000

Revenue: 1Y change, then growth a year; margins are averages

Revenue growth1Y+18.1%3Y+12.9%/yr5Y+11.0%/yr to Mar10Y+9.2%/yr to Mar
OPM average3Y16.1%5Y15.9% to Mar
NPM average3Y9.7%5Y9.7% to Mar

Return on capital

ROCE was 16.6% for the four quarters to Sep 2026, down from 19.2% in the year to Mar 2022

Four quarters to Sep 202616.6% ROCE
10%17.5%Sep 22Sep 24Sep 26

ROCE average

1Y3Y5Y10Y1Y16.6%3Y12.3% to Mar5Y14.2% to Mar10Y19.4% to Mar

Profit and cash

Cash from operations was 123% of profit over five years, 148% in the year to Mar 2026

Yearly profit, cash from operations and free cash flow, ₹ crore

FY26₹1,023 crore operating cashProfit ₹689 crore · Free cash ₹848 crore
FY22
FY23
FY24
FY25
FY26
₹1,250−₹250

Profit growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+40.5%3Y+26.6%/yr5Y+0.9%/yr to Mar10Y+9.7%/yr to Mar

Reinvestment

Capex was ₹175 crore in the year to Mar 2026, 0.5 times depreciation

FY26₹175 crore capexWork in progress ₹110 crore
FY22
FY23
FY24
FY25
FY26
0₹1,250

Capex growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y−35.3% to Mar3Y−41.5%/yr to Mar5YToo short10YToo short

BorrowingsInsufficient history, from Dec 2022Insufficient history, from Dec 2022

Debt ÷ equity 0.03 at 30 Sep 2026; profit covered interest 66.8x over the last four quarters

Sep 2026 balance sheet0.03 debt ÷ equityNet cash ₹1,800 crore
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
0100x

Safety

Now3Y ago
Debt ÷ equity0.033Y ago0.03
Int. cover66.8x3Y ago66.8x

Operating health

Working capital rose from 65 to 69 days in 5 years

Year to Mar 202669 days working capital
60120Mar 22Mar 24Mar 26
Working cap.691Y−83Y+15Y+4
Debtor741Y03Y+175Y+2
Inventory901Y−73Y−115Y−38

OwnershipInsufficient history, from Mar 2023Insufficient history, from Mar 2023

FIIs own 8.90%, up 0.59 points in a year. Promoters hold 45.33%

Share of the company held, %, by quarter end

Sep 2026 quarter8.90% FIIs
10%40%Sep 23Sep 24Sep 25Sep 26

Change in holding, in points

FIIs1Y+0.593Y+1.19
Promoters1Y+0.123Y+0.28

Atul Ltd · ATUL · Dyes & Pigments · price as of the 12 November 2026 close, updated every trading day · results updated weekly · research updated 17 May 2026

Atul share price today: ₹5,208.00 at the close on 12 November 2026, down 12.0% in a year. Atul (ATUL) is worth ₹15,334 crore, trades at a P/E of 19.9 and has closed between ₹5,028.50 and ₹7,100.00 over the past 52 weeks. Latest change: profit fell in the September 2026 quarter.

MixedBusiness trend from the last 12 quarters
₹5,208.00Price −12.0% in a year
19.9×P/E lower than 97% of the last 11 years
₹1,877 CrRevenue (Sep 2026) +20.9% on a year ago
₹159 CrProfit (Sep 2026) −12.6% on a year ago
13.2%Operating margin −4.0 points on a year ago
16.6%ROCE four quarters to Sep 2026
13.4%ROIC against a 12.0% cost of capital: +1.4 points

Atul Ltd's P/E is near the low end of its own history, higher than only 3% of past readings, and its quarterly results are still getting worse.

The main question: earnings per share (last four quarters) moved +42.4% while the share price moved −12.0%.

The price has been falling for 5 weeks, and the P/E is lower than 97% of its own last 11 years. Over the last four quarters, results have been deteriorating, with profit −12.6% on a year earlier, and 152% of the last 3 years' profit came in as cash. What will decide it: whether the price catches up with earnings that have already grown.

What is the Atul share price today?

Atul Ltd's share price was ₹5,208.00 at the close on 12 November 2026. It has been falling for 5 weeks. That is 16.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹5,029 and ₹7,100, and at that close it sat 9% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Atul Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running.

Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?

Ahead in 256 of 552 weeks

Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?
Week13-week return vs NIFTY 500
26 Feb 2016no NIFTY 500 reading
4 Mar 2016no NIFTY 500 reading
11 Mar 2016no NIFTY 500 reading
18 Mar 2016no NIFTY 500 reading
23 Mar 2016no NIFTY 500 reading
1 Apr 2016no NIFTY 500 reading
8 Apr 2016no NIFTY 500 reading
13 Apr 2016no NIFTY 500 reading
22 Apr 2016no NIFTY 500 reading
29 Apr 2016no NIFTY 500 reading
6 May 2016no NIFTY 500 reading
13 May 2016no NIFTY 500 reading
20 May 2016no NIFTY 500 reading
27 May 2016+27.4%
3 Jun 2016+18.9%
10 Jun 2016+18.9%
17 Jun 2016+18.4%
24 Jun 2016+13.4%
1 Jul 2016+22.7%
8 Jul 2016+13.6%
15 Jul 2016+11.8%
22 Jul 2016+10.1%
29 Jul 2016−4.8%
5 Aug 2016−7.0%
12 Aug 2016−11.0%
19 Aug 2016+2.6%
26 Aug 2016+2.9%
2 Sep 2016+8.9%
9 Sep 2016+5.8%
16 Sep 2016+6.0%
23 Sep 2016+13.8%
30 Sep 2016+5.5%
7 Oct 2016+12.1%
14 Oct 2016+10.1%
21 Oct 2016+13.1%
30 Oct 2016+21.3%
4 Nov 2016+11.1%
11 Nov 2016+15.7%
18 Nov 2016+3.7%
25 Nov 2016+1.7%
2 Dec 2016+4.2%
9 Dec 2016+5.8%
16 Dec 2016+3.5%
23 Dec 2016−1.0%
30 Dec 2016−2.0%
6 Jan 2017−8.6%
13 Jan 2017−6.4%
20 Jan 2017−10.1%
27 Jan 2017−7.1%
3 Feb 2017+4.5%
10 Feb 2017−2.2%
17 Feb 2017−5.3%
23 Feb 2017−0.9%
3 Mar 2017−6.3%
10 Mar 2017−12.0%
17 Mar 2017−5.0%
24 Mar 2017−4.6%
31 Mar 2017+0.0%
7 Apr 2017+4.6%
13 Apr 2017+5.3%
21 Apr 2017+5.1%
28 Apr 2017−1.1%
5 May 2017−6.7%
12 May 2017−2.3%
19 May 2017+9.1%
26 May 2017+6.8%
2 Jun 2017+6.0%
9 Jun 2017+6.4%
16 Jun 2017+1.5%
23 Jun 2017+4.7%
30 Jun 2017−3.4%
7 Jul 2017−3.0%
14 Jul 2017−7.7%
21 Jul 2017−14.7%
28 Jul 2017−15.6%
4 Aug 2017−17.8%
11 Aug 2017−21.0%
18 Aug 2017−23.9%
24 Aug 2017−24.1%
1 Sep 2017−16.3%
8 Sep 2017−15.2%
15 Sep 2017−15.4%
22 Sep 2017−6.1%
29 Sep 2017−4.0%
6 Oct 2017−10.9%
13 Oct 2017−8.4%
19 Oct 2017+1.6%
27 Oct 2017+1.0%
3 Nov 2017+17.7%
10 Nov 2017+16.0%
17 Nov 2017+14.4%
24 Nov 2017+17.9%
1 Dec 2017+14.0%
8 Dec 2017+13.1%
15 Dec 2017+10.3%
22 Dec 2017+4.6%
29 Dec 2017+6.0%
5 Jan 2018+13.3%
12 Jan 2018+17.8%
19 Jan 2018+11.2%
25 Jan 2018+15.9%
2 Feb 2018+2.4%
9 Feb 2018+7.5%
16 Feb 2018+8.1%
23 Feb 2018+5.6%
1 Mar 2018+4.3%
9 Mar 2018+2.8%
16 Mar 2018+6.3%
23 Mar 2018+0.5%
28 Mar 2018+0.4%
6 Apr 2018+1.5%
13 Apr 2018−5.3%
20 Apr 2018−0.8%
27 Apr 2018+4.7%
4 May 2018+3.3%
11 May 2018+3.2%
18 May 2018+4.1%
25 May 2018+3.2%
1 Jun 2018−0.3%
8 Jun 2018+1.2%
15 Jun 2018−0.6%
22 Jun 2018+1.7%
29 Jun 2018−1.0%
6 Jul 2018−2.0%
13 Jul 2018+1.8%
20 Jul 2018+4.4%
27 Jul 2018−8.3%
3 Aug 2018+0.4%
10 Aug 2018+4.2%
17 Aug 2018−0.2%
24 Aug 2018+2.4%
31 Aug 2018+11.7%
7 Sep 2018+14.7%
14 Sep 2018+16.4%
21 Sep 2018+14.5%
28 Sep 2018+20.9%
5 Oct 2018+18.2%
12 Oct 2018+21.9%
19 Oct 2018+22.3%
26 Oct 2018+26.8%
2 Nov 2018+22.2%
9 Nov 2018+17.9%
16 Nov 2018+26.1%
22 Nov 2018+26.3%
30 Nov 2018+14.9%
7 Dec 2018+11.5%
14 Dec 2018+6.9%
21 Dec 2018+12.4%
28 Dec 2018+7.7%
4 Jan 2019+9.7%
11 Jan 2019+2.9%
18 Jan 2019+3.6%
25 Jan 2019+6.3%
1 Feb 2019+3.0%
8 Feb 2019+3.1%
15 Feb 2019−2.1%
22 Feb 2019−4.6%
1 Mar 2019−4.7%
8 Mar 2019−6.2%
15 Mar 2019−5.9%
22 Mar 2019−8.5%
29 Mar 2019−1.4%
5 Apr 2019−4.0%
12 Apr 2019−5.9%
18 Apr 2019−7.1%
26 Apr 2019−8.8%
3 May 2019−4.7%
10 May 2019+0.7%
17 May 2019+1.8%
24 May 2019+2.9%
31 May 2019+12.7%
7 Jun 2019+18.0%
14 Jun 2019+26.2%
21 Jun 2019+17.4%
28 Jun 2019+10.0%
5 Jul 2019+15.4%
12 Jul 2019+10.2%
19 Jul 2019+9.0%
26 Jul 2019+11.9%
2 Aug 2019+9.6%
9 Aug 2019+2.9%
16 Aug 2019+2.1%
23 Aug 2019+3.0%
30 Aug 2019−1.8%
6 Sep 2019−6.5%
13 Sep 2019−2.2%
20 Sep 2019−1.1%
27 Sep 2019+6.6%
4 Oct 2019+2.3%
11 Oct 2019+9.4%
18 Oct 2019+11.6%
27 Oct 2019+10.6%
1 Nov 2019+11.1%
8 Nov 2019+8.5%
15 Nov 2019+3.1%
22 Nov 2019+6.2%
29 Nov 2019+3.3%
6 Dec 2019+9.0%
13 Dec 2019−3.0%
20 Dec 2019−1.9%
27 Dec 2019−6.6%
3 Jan 2020−2.4%
10 Jan 2020−2.6%
17 Jan 2020−1.9%
24 Jan 2020+3.4%
1 Feb 2020+8.9%
7 Feb 2020+13.5%
14 Feb 2020+20.6%
20 Feb 2020+28.2%
28 Feb 2020+32.5%
6 Mar 2020+36.7%
13 Mar 2020+38.3%
20 Mar 2020+38.1%
27 Mar 2020+30.3%
3 Apr 2020+21.2%
9 Apr 2020+22.7%
17 Apr 2020+30.1%
24 Apr 2020+22.2%
30 Apr 2020+24.5%
8 May 2020+18.1%
15 May 2020+17.1%
22 May 2020+3.3%
29 May 2020−0.9%
5 Jun 2020−4.8%
12 Jun 2020−13.8%
19 Jun 2020−19.7%
26 Jun 2020−14.3%
3 Jul 2020−6.3%
10 Jul 2020−3.8%
17 Jul 2020−19.6%
24 Jul 2020−9.6%
31 Jul 2020−15.8%
7 Aug 2020−10.8%
14 Aug 2020−12.0%
21 Aug 2020+7.4%
28 Aug 2020+21.8%
4 Sep 2020+20.0%
11 Sep 2020+20.9%
18 Sep 2020+40.5%
25 Sep 2020+26.5%
1 Oct 2020+24.5%
9 Oct 2020+15.2%
16 Oct 2020+21.6%
23 Oct 2020+18.3%
30 Oct 2020+11.5%
6 Nov 2020+7.8%
14 Nov 2020+9.6%
20 Nov 2020+4.2%
27 Nov 2020−12.6%
4 Dec 2020−19.9%
11 Dec 2020−20.4%
18 Dec 2020−27.4%
24 Dec 2020−16.4%
1 Jan 2021−17.1%
8 Jan 2021−11.0%
15 Jan 2021−13.9%
22 Jan 2021−13.4%
29 Jan 2021−18.6%
5 Feb 2021−16.5%
12 Feb 2021−11.6%
19 Feb 2021−17.2%
26 Feb 2021−13.6%
5 Mar 2021−4.8%
12 Mar 2021+2.2%
19 Mar 2021−1.6%
26 Mar 2021+1.0%
1 Apr 2021+10.1%
9 Apr 2021+18.8%
16 Apr 2021+18.3%
23 Apr 2021+12.0%
30 Apr 2021+25.0%
7 May 2021+29.6%
14 May 2021+18.2%
21 May 2021+25.6%
28 May 2021+25.7%
4 Jun 2021+23.2%
11 Jun 2021+20.8%
18 Jun 2021+22.5%
25 Jun 2021+17.1%
2 Jul 2021+16.0%
9 Jul 2021+3.8%
16 Jul 2021+7.6%
23 Jul 2021+9.6%
30 Jul 2021−0.6%
6 Aug 2021−1.4%
13 Aug 2021−0.8%
20 Aug 2021−1.5%
27 Aug 2021−3.7%
3 Sep 2021−3.4%
9 Sep 2021−6.6%
17 Sep 2021−3.6%
24 Sep 2021−4.7%
1 Oct 2021−6.1%
8 Oct 2021−0.4%
14 Oct 2021−2.5%
22 Oct 2021−9.8%
29 Oct 2021−8.6%
4 Nov 2021−13.5%
12 Nov 2021−12.6%
18 Nov 2021−11.5%
26 Nov 2021−9.5%
3 Dec 2021−5.4%
10 Dec 2021−3.3%
17 Dec 2021−9.5%
24 Dec 2021−7.2%
31 Dec 2021−8.9%
7 Jan 2022−11.9%
14 Jan 2022+0.7%
21 Jan 2022+4.5%
28 Jan 2022+8.1%
4 Feb 2022+9.1%
11 Feb 2022+13.9%
18 Feb 2022+9.5%
25 Feb 2022+13.5%
4 Mar 2022+3.4%
11 Mar 2022+10.3%
17 Mar 2022+14.2%
25 Mar 2022+16.2%
1 Apr 2022+9.6%
8 Apr 2022+10.5%
13 Apr 2022−3.6%
22 Apr 2022+2.4%
29 Apr 2022−3.4%
6 May 2022−1.4%
13 May 2022−7.3%
20 May 2022−4.6%
27 May 2022−9.3%
3 Jun 2022−5.5%
10 Jun 2022−7.0%
17 Jun 2022−6.9%
24 Jun 2022−11.7%
1 Jul 2022−7.6%
8 Jul 2022−8.4%
15 Jul 2022−9.3%
22 Jul 2022−8.7%
29 Jul 2022−4.1%
5 Aug 2022+1.1%
12 Aug 2022+1.0%
19 Aug 2022+0.0%
26 Aug 2022+2.5%
2 Sep 2022+4.7%
9 Sep 2022−3.5%
16 Sep 2022−1.9%
23 Sep 2022+7.7%
30 Sep 2022+2.7%
7 Oct 2022+0.5%
14 Oct 2022−1.4%
21 Oct 2022−8.9%
28 Oct 2022−10.6%
4 Nov 2022−13.7%
11 Nov 2022−11.4%
18 Nov 2022−14.3%
25 Nov 2022−13.8%
2 Dec 2022−7.2%
9 Dec 2022−11.9%
16 Dec 2022−13.8%
23 Dec 2022−20.8%
30 Dec 2022−11.3%
6 Jan 2023−15.2%
13 Jan 2023−14.8%
20 Jan 2023−12.0%
27 Jan 2023−11.7%
3 Feb 2023−10.9%
10 Feb 2023−10.1%
17 Feb 2023−4.4%
24 Feb 2023−4.8%
3 Mar 2023−14.7%
10 Mar 2023−5.8%
17 Mar 2023−6.4%
24 Mar 2023−4.7%
31 Mar 2023−11.3%
6 Apr 2023−7.8%
13 Apr 2023−4.3%
21 Apr 2023−4.7%
28 Apr 2023−4.7%
5 May 2023−10.2%
12 May 2023−5.6%
19 May 2023−14.8%
26 May 2023−12.5%
2 Jun 2023−11.4%
9 Jun 2023−16.1%
16 Jun 2023−11.2%
23 Jun 2023−12.8%
30 Jun 2023−12.3%
7 Jul 2023−15.0%
14 Jul 2023−21.2%
21 Jul 2023−12.9%
28 Jul 2023−14.0%
4 Aug 2023−4.6%
11 Aug 2023−11.4%
18 Aug 2023−7.0%
25 Aug 2023−5.6%
1 Sep 2023+0.8%
8 Sep 2023+2.8%
15 Sep 2023−3.7%
22 Sep 2023−5.2%
29 Sep 2023−2.4%
6 Oct 2023−1.0%
13 Oct 2023+3.4%
20 Oct 2023−3.5%
27 Oct 2023−4.9%
3 Nov 2023−10.4%
12 Nov 2023−6.7%
17 Nov 2023−5.1%
24 Nov 2023−11.1%
1 Dec 2023−17.6%
8 Dec 2023−17.3%
15 Dec 2023−12.2%
22 Dec 2023−12.3%
29 Dec 2023−11.6%
5 Jan 2024−12.1%
12 Jan 2024−13.4%
20 Jan 2024−18.9%
25 Jan 2024−17.1%
2 Feb 2024−17.6%
9 Feb 2024−17.3%
16 Feb 2024−18.9%
23 Feb 2024−15.6%
2 Mar 2024−12.4%
7 Mar 2024−14.3%
15 Mar 2024−18.8%
22 Mar 2024−20.0%
28 Mar 2024−26.2%
5 Apr 2024−22.2%
12 Apr 2024−15.1%
19 Apr 2024−15.6%
26 Apr 2024−12.3%
3 May 2024−6.7%
10 May 2024−10.4%
18 May 2024−11.7%
24 May 2024−12.7%
31 May 2024−16.1%
7 Jun 2024−16.0%
14 Jun 2024−8.7%
21 Jun 2024−1.3%
28 Jun 2024+2.0%
5 Jul 2024+3.3%
12 Jul 2024−0.6%
19 Jul 2024+7.2%
26 Jul 2024+15.3%
2 Aug 2024+16.5%
9 Aug 2024+24.4%
16 Aug 2024+22.2%
23 Aug 2024+21.4%
30 Aug 2024+28.9%
6 Sep 2024+27.7%
13 Sep 2024+19.6%
20 Sep 2024+9.6%
27 Sep 2024+12.1%
4 Oct 2024+11.1%
11 Oct 2024+11.4%
18 Oct 2024+12.2%
25 Oct 2024+1.4%
1 Nov 2024+0.0%
8 Nov 2024+2.1%
14 Nov 2024−1.7%
22 Nov 2024−2.9%
29 Nov 2024−5.7%
6 Dec 2024−5.9%
13 Dec 2024−5.4%
20 Dec 2024−0.4%
27 Dec 2024+0.0%
3 Jan 2025−4.8%
10 Jan 2025−4.9%
17 Jan 2025−7.6%
24 Jan 2025−5.0%
1 Feb 2025−15.4%
7 Feb 2025−18.0%
14 Feb 2025−20.2%
21 Feb 2025−14.3%
28 Feb 2025−14.9%
7 Mar 2025−9.4%
13 Mar 2025−14.1%
21 Mar 2025−12.7%
28 Mar 2025−8.2%
4 Apr 2025−13.6%
11 Apr 2025−15.0%
17 Apr 2025−19.0%
25 Apr 2025−5.7%
2 May 2025+12.0%
9 May 2025+3.4%
16 May 2025+15.8%
23 May 2025+19.5%
30 May 2025+21.8%
6 Jun 2025+14.3%
13 Jun 2025+16.5%
20 Jun 2025+9.5%
27 Jun 2025+10.1%
4 Jul 2025+26.6%
11 Jul 2025+19.3%
18 Jul 2025+16.8%
25 Jul 2025−0.6%
1 Aug 2025−10.5%
8 Aug 2025−3.0%
14 Aug 2025−8.3%
22 Aug 2025−9.7%
29 Aug 2025−12.3%
5 Sep 2025−13.5%
12 Sep 2025−11.0%
19 Sep 2025−7.2%
26 Sep 2025−16.0%
3 Oct 2025−17.8%
10 Oct 2025−17.9%
17 Oct 2025−15.7%
24 Oct 2025−15.5%
31 Oct 2025−15.7%
7 Nov 2025−19.2%
14 Nov 2025−10.1%
21 Nov 2025−13.3%
28 Nov 2025−10.2%
5 Dec 2025−8.3%
12 Dec 2025−7.5%
19 Dec 2025−8.2%
26 Dec 2025−3.8%
2 Jan 2026−4.3%
9 Jan 2026+0.3%
16 Jan 2026+4.7%
23 Jan 2026+2.4%
1 Feb 2026+5.1%
6 Feb 2026+13.7%
13 Feb 2026+13.2%
20 Feb 2026+12.5%
27 Feb 2026+19.1%
6 Mar 2026+13.3%
13 Mar 2026+15.8%
20 Mar 2026+13.9%
27 Mar 2026+15.5%
2 Apr 2026+10.9%
10 Apr 2026+9.9%
17 Apr 2026+9.3%
24 Apr 2026+15.6%
30 Apr 2026+15.0%
8 May 2026+15.0%
15 May 2026+11.7%
22 May 2026+10.1%
29 May 2026+1.6%
4 Jun 2026+5.1%
5 Jun 2026+0.8%
10 Jun 2026+1.1%
12 Jun 2026−3.5%
17 Jun 2026−2.0%
19 Jun 2026−1.9%
24 Jun 2026−0.3%
25 Jun 2026−1.2%
1 Jul 2026−4.8%
3 Jul 2026−10.9%
10 Jul 2026−15.8%
17 Jul 2026−15.6%
24 Jul 2026−7.7%
31 Jul 2026−4.5%
7 Aug 2026−4.1%
14 Aug 2026−3.1%
21 Aug 2026−4.2%
28 Aug 2026−1.6%
4 Sep 2026−2.0%
11 Sep 2026−4.5%
18 Sep 2026−6.3%
25 Sep 2026−4.2%
1 Oct 2026−4.4%
9 Oct 2026+0.7%
16 Oct 2026+5.3%
23 Oct 2026−6.5%
30 Oct 2026−18.7%
6 Nov 2026−21.7%
12 Nov 2026−22.0%
Each bar is one week, from 2016 to now (552 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the NIFTY 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 11 years the share price moved +283% while the NIFTY 500 moved +282%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 16 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What changed at Atul this quarter?

Three changes stood out: profit fell in the September 2026 quarter, revenue up on a year earlier for 11 quarters in a row and lowest operating margin in 10 quarters.

  1. Profit fell in the September 2026 quarter

    Profit was ₹159 crore, -12.6% on a year earlier (₹182 crore), after 9 quarters of growth.

  2. Revenue up on a year earlier for 11 quarters in a row

    In the September 2026 quarter revenue was ₹1,877 crore, +20.9% on a year earlier.

  3. Lowest operating margin in 10 quarters

    Operating margin was 13% in the September 2026 quarter, against 17% a year earlier.

What are Atul's latest quarterly results?

For July to September 2026 (the quarter ended 30 September 2026), Atul reported revenue of ₹1,877 crore, up 20.9% from ₹1,552 crore a year earlier, and a profit of ₹159 crore, down 12.6% from ₹182 crore.

Atul results: July to September 2026 against a year earlier

Atul results: July to September 2026 against a year earlier
MeasureJuly to September 2026July to September 2025Change
Revenue₹1,877 crore₹1,552 crore+20.9%
Profit₹159 crore₹182 crore−12.6%
Earnings per share₹52.89₹60.88−13.1%
Operating margin13.2%17.2%−4.0 points

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

What is the Atul share price history?

Atul closed at ₹5,208.00 on 12 November 2026, down 12.0% from ₹5,916.50 a year earlier (14 November 2025) and down 40.1% over five years. Its highest weekly close since February 2016 was ₹10,535.20 on 8 October 2021.

Atul share price: then and now

Atul share price: then and now
WhenCloseChange to 12 Nov 2026
1 week ago · 5 Nov 2026₹5,260.00−1.0%
1 month ago · 12 Oct 2026₹5,978.50−12.9%
6 months ago · 15 May 2026₹7,100.00−26.6%
1 year ago · 14 Nov 2025₹5,916.50−12.0%
3 years ago · 12 Nov 2023₹6,656.55−21.8%
5 years ago · 12 Nov 2021₹8,695.05−40.1%
10 years ago · 11 Nov 2016₹2,160.25+141.1%
Earliest and lowest weekly close in our records · 26 Feb 2016₹1,360.70+282.7%
Highest weekly close since February 2016 · 8 Oct 2021₹10,535.20−50.6%
52-week high (weekly close) · 15 May 2026₹7,100.00−26.6%
52-week low (weekly close) · 30 Oct 2026₹5,028.50+3.6%

Weekly closing prices. Each change is the move from that price to the 12 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

565 weekly closes from 26 February 2016 to 12 November 2026.

What is the latest news on Atul?

12 Nov 2026: Atul closed at ₹5,208.00, down 1.0% on the week and down 12.9% on the month. Results for July to September 2026: Revenue up 20.9% and profit down 12.6% on a year earlier.

Earlier

  • 17 Jul 2026: ex-date for a dividend of ₹30 a share.
  • Our read, 17 May 2026: FY24-cycle trough is confirmed behind, a depressed-base specialty chemicals compounder turning the corner on volumes, margins, and new product cadence.

Our read of the business

FY26 closed with profit +38% on a year earlier to ₹689 Cr (EPS ₹230) after FY24 earnings trough, consecutive quarterly profit acceleration from Q1 to January to March 2026, all four quarters above the prior-year comparable. Operating margin structurally improved to 17-20% range (from 13-16% in FY24-FY25 trough), driven by better product mix in Life Science (PBIT 19%) and operating leverage in Performance Chemicals. ₹1,200 Cr surplus funds + near-zero debt = capital spending optionality preserved.

Latest quarter: Record quarterly sales, but profit boosted by ₹90 Cr other income and provision reversal.

Our read after the latest results, written 17 May 2026.

What dividend does Atul pay?

Atul paid ₹30 a share in regular dividends in the 12 months to 12 November 2026 (1 payment), a yield of 0.58% at the ₹5,208.00 close on 12 November 2026. The last was a dividend of ₹30 a share, ex-date 17 July 2026.

Atul dividends since 1 April 2021

Atul dividends since 1 April 2021
Ex-dateDividend per shareTypeRecord date
17 Jul 2026Dividend₹30Dividendsame day
11 Jul 2025Dividend₹25Dividendsame day
12 Jul 2024Dividend₹20Dividend—
14 Jul 2023Dividend₹25Dividend—
2 Nov 2022Special₹7.50Special3 Nov 2022
14 Jul 2022Dividend₹25Dividend—
15 Jul 2021Dividend₹20Dividend—

Amounts as the company declared them on the exchange. A dividend goes to whoever owns the shares before the ex-date.

5 of 5Of the last 5 financial years, years with an exchange dividend record

Yes. Atul Ltd paid out 13% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the exchange corporate-actions record, read 12 November 2026.

What did Atul management say on the latest results call?

Atul's management made 0 promises we could check against what it later reported.

Our read after the latest results, written 17 May 2026.

What is the future of Atul? What is changing in the business?

What is changing at Atul, from the latest results and calls: specialty chemicals destocking cycle end, volume recovery, life science chemicals, margin premium + export growth (2,4-d, indoxacarb, sulphonyl urea) and liquid epoxy resin (ler) facility ramp, new capacity driving performance chemicals.

  • Specialty Chemicals Destocking Cycle End, Volume Recovery. Revenue grew 7 consecutive quarters through FY26, with 4 consecutive quarters of on a year earlier profit acceleration, the global agro-chemical and specialty chemicals destocking cycle that cratered FY24 earnings is definitively over. ⚠ estimate
  • Life Science Chemicals, Margin Premium + Export Growth (2,4-D, Indoxacarb, Sulphonyl Urea). Life Science segment runs 19% PBIT margins vs 10% for Performance Chemicals, growing crop protection export volumes (2,4-D, Indoxacarb, Sulphonyl Urea herbicides/insecticides) improve the revenue mix and lift blended margins structurally. ⚠ estimate
  • Liquid Epoxy Resin (LER) Facility Ramp, New Capacity Driving Performance Chemicals. The recently commissioned LER plant drove July to September 2025 domestic volume uplift, higher LER volumes from new facility was explicitly cited as the key Q2 on a year earlier revenue driver in the company presentation. ⚠ estimate
  • New Product Launches, Crop Protection Retail + Water Treatment JV. Three new crop protection products (Mylonis, Salix Gold, Tikadis, May 2026) goal India's ₹25,000 Cr+ crop protection market; Atul-Buckman water treatment JV (Feb 2026) opens a new segment. ⚠ estimate

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the latest results, written 17 May 2026.

What could change the Atul story? What are the risks?

China remains the structural headwind, if export pricing aggression resumes (driven by domestic oversupply or policy shifts), Atul's agro-chemical and dye segments face margin re-compression similar to FY24.

The main risks

  • Chinese Specialty Chemicals Competition Resumes Aggression: China remains the structural headwind, if export pricing aggression resumes (driven by domestic oversupply or policy shifts), Atul's agro-chemical and dye segments face margin re-compression similar to FY24. ⚠ estimate
  • Other Income Dependency, Q4 profit Quality Concern: January to March 2026 profit of ₹210 Cr included ₹90 Cr other income (31.9% of PBDIT) and a ₹24 Cr employee provision reversal, strip these out and core profit is ~₹96 Cr, implying profit quality significantly weaker than headline. ⚠ estimate
  • Agro-Chemical Demand Cyclicality, Monsoon Sensitivity: Crop Protection is both Life Science's largest driver and inherently cyclical, a poor FY27 monsoon, farm income stress, or channel restocking pause can abruptly reverse the recovery. ✓ fact
  • Input Cost Volatility, Benzene, Toluene, Petrochemical Feedstocks: Atul uses benzene, toluene, and other crude-linked petrochemical feedstocks as raw materials, an oil price spike compresses margins; current recovery partially aided by favorable feedstock costs. ⚠ estimate

Our read after the latest results, written 17 May 2026.

What to watch in Atul's next results?

When Atul reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Chinese benzene/agrochemical export price indices; Atul's quarterly operating margin trend vs prior year.

Atul: what to watch next quarter
What to checkWhy
Chinese benzene/agrochemical export price indices; Atul's quarterly operating margin trend vs prior year.Chinese Specialty Chemicals Competition Resumes Aggression
Brent crude trajectory; on the previous quarter operating margin movement if crude spikes.Input Cost Volatility, Benzene, Toluene, Petrochemical Feedstocks
Capital spending announcement or special dividend/buyback announcement; quarterly ROCE trend.ROE / ROCE Improvement Stall, Surplus Funds Drag on Returns

Which stock lists is Atul on?

Atul is on 3 of our India lists: Undervalued stocks, 52 week high & low and Small & mid cap stocks.

Is Atul profitable?

Atul Ltd earned ₹159 Cr of net profit in the Sep 2026 quarter, −12.6% on the same quarter a year earlier. Full-year FY26 profit was ₹689 Cr. Over 10 years profit has grown 9.7% a year on average. The Sep 2026 quarter's profit is 8.5% of that quarter's revenue. The same quarter a year earlier earned ₹182 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹689 Cr (+38.1% on the year before).

Why profit moved: revenue changed +20.9% on a year earlier and the margin moved −4.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed +45.6% and revenue +18.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

How much revenue does Atul make, and is it growing?

Atul Ltd reported ₹1,877 Cr of revenue in the Sep 2026 quarter, +20.9% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 10 years it has grown 9.2% a year on average. The last full year, FY26, came in at ₹6,274 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. As confirmed in the Q2 FY26 company presentation: 'The Company maintains a strong Balance Sheet with ~₹1,200 cr of surplus funds available for future expansion.' Net D/E of -0.18 (net cash). Current funds of ₹1,159 Cr as at Sep 30, 2025. This is both a quality floor (no financial risk) and a potential catalyst if capex is announced with a clear returns thesis.

The last four reported quarters add to ₹6,969 Cr.

FY26 revenue was ₹6,274 Cr, +12.4% on the year before.

Recent pace: the last four quarters grew +18.0% on average, against 9.2% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +18.1%, against +17.3% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +40.5%, against +43.4% a year (stabilising).

Watch next

Metric
Capex Optionality, ₹1,200 Cr Surplus Funds Available for…
Threshold
Chinese benzene/agrochemical export price indices; Atul's quarterly OPM trend vs prior year
Which result
the next result

How much of every ₹100 of sales does Atul keep?

Atul Ltd's operating margin was 13.2% in the Sep 2026 quarter, 4.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 13.5% and 24.6%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. H1 FY26 segment data from the official company presentation shows Life Science Chemicals PBIT% at 19% versus Performance & Other Chemicals at 10%. Export-led growth in Crop Protection, Bulk Actives (2,4-D herbicide, Indoxacarb insecticide, Sulphonyl Urea) drove the Life Science segment 7% YoY in H1, with export realizations recovering. If Life Science grows faster than Performance Chemicals, the blended EBITDA margin will expand even without volume growth in the lower-margin segment.

Why the margin moved: operating margin changed −4.1 percentage points on the year while gross margin changed −6.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Watch next

Metric
Life Science Chemicals, Margin Premium + Export Growth…
Threshold
Chinese benzene/agrochemical export price indices; Atul's quarterly OPM trend vs prior year
Which result
the next result

Is Atul's profit turning into cash?

Over the last 3 years, 152% of Atul Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹1,023 Cr of operating cash against ₹689 Cr of profit. After ₹175 Cr of spending on assets, ₹848 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 152% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Where does Atul's cash go?

Atul Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 70 days in FY26, down from 78 days in FY21. It spent ₹949 Cr on assets over the last 3 years. Customers take 74 days to pay, and stock sits for 90 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹6,274 Cr, each day of that cycle ties up about ₹17.2 Cr, so roughly ₹1,203 Cr is tied up in the business at any time.

FY26: customers took 74 days to pay and stock sat for 90 days, about 3.0 months of sales sitting as stock, for a full cycle of 70 days, shorter than FY21's 78.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 90 days. Customers pay about 74 days after that. Suppliers are paid at 94 days. Together that makes the 70-day cycle.

Spending on assets: ₹949 Cr over the last 3 years, against ₹882 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹110 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

What is Atul's P/E ratio, and how does it compare with its own history?

Atul Ltd's P/E is 19.9×, near the low end of its own history: it has been lower only 3% of the time. Its usual P/E (the middle reading) is 32.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

19.9×P/E · lower than 97% of its last 11 years
1.46PEG · today, derived from 3-year earnings growth

Why the multiple is where it is: over the past year earnings per share moved +42.4% while the price moved −12.0%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 3 years the price moved −7.9% a year; about +25.4% a year came from earnings growth and about −33.3 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Is the Atul business getting better or worse?

Atul Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 16.6% (four quarters to Sep 2026); each line tells part of the story. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Steady highRevenue growth · latest (Sep 2026) +18.1%, range −15.9% to +18.2%
FlatProfit growth · latest (Sep 2026) +40.5%, range −36.6% to +56.3%
FlatEPS growth · latest (Sep 2026) +42.4%, range −37.1% to +59.1%
RisingROCE · latest (four quarters to Sep 2026) 16.6%, range 8.8% to 16.9%

Why it matters: when the lines disagree, each line above matters more than any single label.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+12.4%+4.9%+11.0%+9.2%
Profit+38.1%+10.8%+0.9%+9.7%
EPS+40.1%+9.7%+0.8%+9.6%
Share price−12.0%−7.9%−9.7%+9.2%
+20.9%Revenue growth (Sep 2026) · latest quarter against a year ago
−12.6%Profit growth (Sep 2026) · latest quarter against a year ago
9.2%Revenue, 10 years · yearly growth over the long run

What is the Atul story, and has it been checked?

Atul Ltd's story is not scored yet against the checks our research set on 17 May 2026. Where it sits in its own cycle: mid contraction.

NOT YET CHECKED

Our read, 17 May 2026. FY24-cycle trough is confirmed behind, a depressed-base specialty chemicals compounder turning the corner on volumes, margins, and new product cadence.

From the price. Price stage 4, week 5, below its 200-day line, relative strength falling.

Where they disagree. FII stake-cutting per pe pb cycle data.

What is not proven yet. China remains the structural headwind, if export pricing aggression resumes (driven by domestic oversupply or policy shifts), Atul's agro-chemical and dye segments face margin re-compression similar to FY24.

The test written in advance. Chinese Specialty Chemicals Competition Resumes Aggression. Measured by: Chinese Specialty Chemicals Competition Resumes Aggression Chinese benzene/agrochemical export price indices; Atul's quarterly OPM trend vs prior year by the next result.

The test written in advance. Other Income Dependency, Q4 PAT Quality Concern. Measured by: Other Income Dependency, Q4 PAT Quality Concern Q1 FY27 other income component; core EBITDA trajectory vs reported PAT by the next result.

The test written in advance. Agro-Chemical Demand Cyclicality, Monsoon Sensitivity. Measured by: Agro-Chemical Demand Cyclicality, Monsoon Sensitivity IMD monsoon forecast; domestic agrochemical channel inventory commentary in Q1 FY27 by the next result.

The key numbers to watch, and the level that would change the picture

The key numbers to watch, and the level that would change the picture
MeasureNowWhy it matters
Specialty Chemicals Destocking Cycle End…HIGHRevenue grew 7 consecutive quarters through FY26, with 4 consecutive quarters of YoY PAT acceleration, the global agro-chemical…
Life Science Chemicals, Margin Premium +…HIGHLife Science segment runs 19% PBIT margins vs 10% for Performance Chemicals, growing crop protection export volumes (2,4-D…
Liquid Epoxy Resin (LER) Facility Ramp…MEDIUM HIGHThe recently commissioned LER plant drove Q2 FY26 domestic volume uplift, higher LER volumes from new facility was explicitly…
New Product Launches, Crop Protection…MEDIUMThree new crop protection products (Mylonis, Salix Gold, Tikadis, May 2026) goal India's ₹25,000 Cr+ crop protection market…
Capex Optionality, ₹1,200 Cr Surplus…MEDIUMWith ₹1,200 Cr in surplus funds and near-zero debt, Atul has an unlevered balance sheet that can fund significant new capacity…

Everything further down this page is evidence for or against these.

The numbersmid-way through a fall in resultsFY26-Q1 to FY26-Q4
The pricefalling, below the 200-day averageFY26-Q1 to FY26-Q4

FY26-Q1FY26-Q4

  • 1 · Operating leveragebuilding
  • 2 · Value-added mixbuilding
  • 3 · Management changebuilding
  • 4 · Paying down debtquiet
  • 5 · Regulatory approvalbuilding
  • 6 · Order-book winsbuilding
  • 7 · Consolidationquiet
  • 8 · Demerger or value unlockquiet
  • 9 · Buybackquiet
  • 10 · New geographiesquiet
  • 11 · More business from existing customersquiet
  • 12 · New product launchquiet
  • 13 · Mandatory normsquiet
  • 14 · A bigger market to servequiet
  • 15 · Market-share gainsquiet
  • 16 · Asset qualityquiet

Lever 3 · Management change: building. Revenue grew 7 consecutive quarters through FY26, with 4 consecutive quarters of YoY PAT acceleration, the global agro-chemical and specialty chemicals destocking cycle that cratered FY24 earnings is definitively over. What proves it keeps working: Specialty Chemicals Destocking Cycle End, Volume Recovery. It stops working if Chinese benzene/agrochemical export price indices; Atul's quarterly OPM trend vs prior year.

Lever 2 · Value-added mix: building. Life Science segment runs 19% PBIT margins vs 10% for Performance Chemicals, growing crop protection export volumes (2,4-D, Indoxacarb, Sulphonyl Urea herbicides/insecticides) improve the revenue mix and lift blended margins structurally. What proves it keeps working: Life Science Chemicals, Margin Premium + Export Growth (2,4-D, Indoxacarb, Sulphonyl Urea).

Lever 5 · Regulatory approval: building. The recently commissioned LER plant drove Q2 FY26 domestic volume uplift, higher LER volumes from new facility was explicitly cited as the key Q2 YoY revenue driver in the company presentation. What proves it keeps working: Liquid Epoxy Resin (LER) Facility Ramp, New Capacity Driving Performance Chemicals.

Lever 1 · Operating leverage: building. Three new crop protection products (Mylonis, Salix Gold, Tikadis, May 2026) goal India's ₹25,000 Cr+ crop protection market; Atul-Buckman water treatment JV (Feb 2026) opens a new segment. What proves it keeps working: New Product Launches, Crop Protection Retail + Water Treatment JV.

Sources: our stock research file (17 May 2026) · quarterly results through Sep 2026. The story check is re-scored every results season; the record below never changes.

The whole page in one table. Each row links to its section.

The whole page in one table. Each row links to its section.
SectionWhere it is nowThe one thing to watch next
Ownershipsee the sectionSpecialty Chemicals Destocking Cycle End, Volume Recovery
Margin17%Life Science Chemicals, Margin Premium + Export Growth…
Safetysee the sectionLiquid Epoxy Resin (LER) Facility Ramp, New Capacity…
Revenue₹1,670 CrCapex Optionality, ₹1,200 Cr Surplus Funds Available for…

How much does Atul earn on its capital?

Atul Ltd earned a ROCE of 15% in FY26. That is up from a low of 9% in FY24. Its return on capital used (ROIC) is 1.4 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 11.0% net margin and 0.80× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 11.0% net margin × 0.80× asset turnover × 1.27× leverage (assets divided by equity) ≈ 11.2% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 13.4% − 12.0% = +1.4 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

The 13.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 11.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Does Atul have too much debt?

Atul Ltd has total debt of ₹169 Cr against shareholder equity of ₹6,583 Cr as of Sep 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.03 in FY22 to 0.03 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

What is the Atul shareholding pattern?

No group of Atul Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved +0.7 points over the same period, to 25.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Why this happened. The FY24 earnings trough (PAT ₹324 Cr, down 36% from FY23) was driven by global agrochemical destocking, Chinese export dumping, and weak European demand. From Q1 FY26, all three conditions began normalizing: channel inventories cleared, Chinese pricing stabilised somewhat, European demand recovered. Each quarter of FY26 printed higher PAT than its prior-year comparable. Performance & Other Chemicals segment drove H1 FY26 revenue growth at 14% YoY, while Life Science Chemicals grew 7%, both segments above FY24 trough rates.

Over the last two years: Foreign institutions: −0.8 points over 8 quarters, to 8.9%; Domestic institutions: +0.7 points over 8 quarters, to 25.2%; Promoters: +0.2 points over 8 quarters, to 45.3%.

Watch next

Metric
Specialty Chemicals Destocking Cycle End, Volume Recovery
Threshold
Chinese benzene/agrochemical export price indices; Atul's quarterly OPM trend vs prior year
Which result
the next result

How far is Atul from balance-sheet trouble?

For Atul Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why this happened. The Q2 FY26 company presentation explicitly states: 'Year-over-year revenue also increased by 12%, driven by higher LER volumes from the recently commissioned facility.' This is new manufactured capacity that had not existed in the prior-year comparables, creating a structural volume step-up that is not a cyclical recovery. The RACL (Rudolf Atul Chemicals Ltd, 50:50 JV with Nouryon for textile chemicals) plant stabilization and LER ramp together represent the capex cycle beginning to pay off.

Watch next

Metric
Liquid Epoxy Resin (LER) Facility Ramp, New Capacity…
Threshold
Chinese benzene/agrochemical export price indices; Atul's quarterly OPM trend vs prior year
Which result
the next result

How does Atul rank in its industry?

54.4 out of 100, rank 5 of 10 in Dyes & Pigments, with 100% of the evidence available.

Atul Ltd scores 54.4 out of 100 against the 10 companies it is compared with in Dyes & Pigments, ranking 5. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 21.3 + 19.4 + 12.9 + 0.8 = 54.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Atul compared with?

Atul ranks 5 of 10 Dyes & Pigments companies on the 4-Factor Sector Score, with 54.4 out of 100.

  1. 1Bodal Chemicals LtdBODALCHEM · breaking out · Most evidence points up · 83% evidence71.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 30.6/35 · Revenue 45% · Profit 100% · Operating margin change 7.2 points · 100% evidenceCapital efficiency 10.3/25 · ROCE 5.6% (year to Mar 2026) · Operating margin 12.4% · 100% evidenceValuation 10.8/20 · P/E 14.2× · PEG — · 15% evidenceRelative strength 20.0/20 · Strength vs its industry (price vs its 52-week average, weekly) 63.1% · Strength vs NIFTY 500 (same reading) 82.7% · 1 year 182.1% · 100% evidence · 11 of 12 weeks aheadExact sum: 30.6 + 10.3 + 10.8 + 20 = 71.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Bhageria Industries LtdBHAGERIA · leader · Most evidence points up · 82% evidence70.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 29.8/35 · Revenue 75.8% · Profit 100% · Operating margin change 8 points · 95% evidenceCapital efficiency 14.3/25 · ROCE 9.4% (year to Mar 2026) · Operating margin 18.6% · 76% evidenceValuation 9.1/20 · P/E 14.8× · PEG — · 50% evidenceRelative strength 17.6/20 · Strength vs its industry (price vs its 52-week average, weekly) 42.5% · Strength vs NIFTY 500 (same reading) 64.2% · 1 year 94.2% · 100% evidence · 12 of 12 weeks aheadExact sum: 29.8 + 14.3 + 9.1 + 17.6 = 70.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Vidhi Specialty Food Ingredients LtdVIDHIING · quiet · Evidence leans up · 75% evidence58.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.6/35 · Revenue 34.4% · Profit 22.4% · Operating margin change -5 points · 100% evidenceCapital efficiency 22.0/25 · ROCE 18.8% (year to Mar 2026) · Operating margin 19% · 100% evidenceValuation 9.9/20 · P/E 25.7× · PEG — · 50% evidenceRelative strength 8.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -4.6% · 1 year -17.1% · 25% evidence · 10 of 12 weeks aheadExact sum: 17.6 + 22 + 9.9 + 8.5 = 58 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Ultramarine & Pigments LtdULTRMARINE · Too little evidence to rank firmly · 55% evidence57.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.9/43.75 · Revenue 21% · Profit 18.6% · Operating margin change 2 points · 95% evidenceCapital efficiency 18.7/31.25 · ROCE 10.8% (year to Mar 2026) · Operating margin 17.9% · 76% evidenceValuation 13.9/25 · P/E 11.4× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 24.9 + 18.7 + 13.9 = 57.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  5. 5Atul Ltd this pageATUL · quiet · Evidence leans up · 100% evidence54.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.3/35 · Revenue 18.1% · Profit 40.5% · Operating margin change -4 points · 100% evidenceCapital efficiency 19.4/25 · ROCE 14.9% (year to Mar 2026) · Operating margin 13.2% · 100% evidenceValuation 12.9/20 · P/E 19.9× · PEG 1.46 · 100% evidenceRelative strength 0.8/20 · Strength vs its industry (price vs its 52-week average, weekly) -33% · Strength vs NIFTY 500 (same reading) -18.8% · 1 year -12% · 100% evidence · 0 of 12 weeks aheadExact sum: 21.3 + 19.4 + 12.9 + 0.8 = 54.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Sudarshan Chemical Industries LtdSUDARSCHEM · losing its lead · Evidence leans up · 85% evidence54.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.4/35 · Revenue 48.8% · Profit 32% · Operating margin change 4 points · 100% evidenceCapital efficiency 8.4/25 · ROCE 5.5% (year to Mar 2026) · Operating margin 9.7% · 100% evidenceValuation 10.6/20 · P/E 107× · PEG 0.75 · 100% evidenceRelative strength 11.6/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 5.9% · 1 year 14% · 25% evidence · 11 of 12 weeks aheadExact sum: 23.4 + 8.4 + 10.6 + 11.6 = 54 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Kiri Industries LtdKIRIINDUS · breaking out · Evidence leans down · 75% evidence47.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.3/35 · Revenue 29.5% · Profit 100% · Operating margin change 4.4 points · 95% evidenceCapital efficiency 4.6/25 · ROCE 3.4% (year to Mar 2026) · Operating margin -1.7% · 76% evidenceValuation 11.5/20 · P/E 0.5× · PEG — · 15% evidenceRelative strength 11.6/20 · Strength vs its industry (price vs its 52-week average, weekly) -11.9% · Strength vs NIFTY 500 (same reading) 5.2% · 1 year -3.1% · 100% evidence · 12 of 12 weeks aheadExact sum: 19.3 + 4.6 + 11.5 + 11.6 = 47 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Sudarshan Colorants India LtdSUDARCOLOR · quiet · Evidence leans down · 90% evidence38.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 10.4/35 · Revenue 6.3% · Profit -9.8% · Operating margin change 3 points · 100% evidenceCapital efficiency 11.7/25 · ROCE 11.4% (year to Mar 2026) · Operating margin 12.6% · 100% evidenceValuation 13.4/20 · P/E 16× · PEG — · 50% evidenceRelative strength 3.2/20 · Strength vs its industry (price vs its 52-week average, weekly) -21% · Strength vs NIFTY 500 (same reading) -4.8% · 1 year -20.3% · 100% evidence · 5 of 12 weeks aheadExact sum: 10.4 + 11.7 + 13.4 + 3.2 = 38.7 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far.
  9. 9Sadhana Nitro Chem LtdSADHNANIQ · quiet · Most evidence points down · 71% evidence32.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 13.0/35 · Revenue -24.3% · Profit -80% · Operating margin change 646.8 points · 74% evidenceCapital efficiency 4.6/25 · ROCE -11.1% (year to Mar 2026) · Operating margin 17.9% · 100% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 4.5/20 · Strength vs its industry (price vs its 52-week average, weekly) -16.3% · Strength vs NIFTY 500 (same reading) -0.9% · 1 year 36.4% · 100% evidence · 4 of 12 weeks aheadExact sum: 13 + 4.6 + 10 + 4.5 = 32.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Indokem LtdMost evidence points down · 60% evidence23.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 7.4/43.75 · Revenue -4.9% · Profit -41.1% · Operating margin change 0.6 points · 95% evidenceCapital efficiency 5.1/31.25 · ROCE 5.5% (year to Mar 2026) · Operating margin 3.6% · 95% evidenceValuation 10.6/25 · P/E 796.4× · PEG — · 15% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 7.4 + 5.1 + 10.6 = 23.1 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Dyes & Pigments, all 10 compared on one page.

Which companies are close to Atul in size?

Atul is the largest of 10 Dyes & Pigments companies on Sector Alpha by market value (at the 12 November 2026 close). It is the largest. Just below it: Sudarshan Chemical Industries, Kiri Industries, Bodal Chemicals, Indokem, Bhageria Industries and Vidhi Specialty Food Ingredients.

Dyes & Pigments companies close in size

  1. Atul Ltd ₹15,333 crore
  2. Sudarshan Chemical Industries Ltd ₹9,399 crore
  3. Kiri Industries Ltd ₹3,322 crore
  4. Bodal Chemicals Ltd ₹2,048 crore
  5. Indokem Ltd ₹1,786 crore
  6. Bhageria Industries Ltd ₹1,676 crore
  7. Vidhi Specialty Food Ingredients Ltd ₹1,551 crore

All 10 Dyes & Pigments companies, largest first

Companies close in size in other industries

  1. Tata Chemicals Ltd ₹15,383 crore · Chemicals - Inorganic - Caustic Soda/Soda Ash
  2. Clean Max Enviro Energy Solutions Ltd ₹15,351 crore · Power Generation & Supply
  3. Atul Ltd ₹15,333 crore
  4. KPIT Technologies Ltd ₹15,298 crore · IT - ER&D
  5. Jammu and Kashmir Bank Ltd ₹15,161 crore · Banks - Private

What else do people ask about Atul?

What is Atul's share price today?

Atul Ltd's share price is ₹5,208.00, −12.0% over the past year. The whole company is worth ₹15,334 Cr on the market.

In the last 52 weeks it traded between ₹5,029 to ₹7,100; today it is 9% of the way up from the low, 16.8% below its 200-day average (as of 12 November 2026).

What were Atul's latest quarterly results?

Atul Ltd reported revenue of ₹1,877 Cr and net profit of ₹159 Cr for the Sep 2026 quarter. Revenue rose 20.9% and profit fell 12.6% compared with a year earlier. Earnings per share were ₹52.89.

The operating margin was 13.2%, 4.0 percentage points lower than a year earlier (as of 12 November 2026).

What is Atul's market cap?

Atul Ltd's market capitalisation is ₹15,334 Cr at a share price of ₹5,208.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 12 November 2026).

How is Atul performing?

Atul Ltd's share price has been falling for 5 weeks. In its latest quarter, revenue rose 20.9% and profit fell 12.6% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 4 weeks running (as of 12 November 2026).

Will Atul's share price go up?

This page does not forecast Atul Ltd's share price. What it shows instead: the share price is ₹5,208.00, and it has been falling for 5 weeks. Its P/E of 19.9× is higher than 3% of its own last 11 years (as of 12 November 2026).

Who owns Atul?

Promoters own 45.3% of Atul Ltd, foreign institutions 8.9%, domestic institutions 25.2% and the public 20.5% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 12 November 2026).

Does Atul have too much debt?

No, Atul Ltd has little debt: its debt is 0.03× its equity, and its operating profit is 67 times its interest bill. At Sep 2026 borrowings were ₹169 Cr against equity of ₹6,583 Cr.

So the returns on this page come from the business, not borrowed money (as of 12 November 2026).

Where is Atul in its business cycle?

Atul Ltd's FY26 operating margin was 16.5%, against a 13-year range of 13.5% to 24.6%. The latest quarter was 13.2%, below the bottom of its own yearly range in the latest quarter, a low point in its cycle.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 12 November 2026).

What could break the Atul story?

The main question: earnings per share (last four quarters) moved +42.4% while the share price moved −12.0%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 12 November 2026).

Is Atul a stock worth studying right now?

What the numbers show: Atul Ltd's P/E is near the low end of its own history, higher than only 3% of past readings, and its quarterly results are still getting worse. The main open question: whether the price catches up with earnings that have already grown.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 12 November 2026).

Is there a Atul share price forecast for 2026?

What is changing at Atul, from the latest results and calls: specialty chemicals destocking cycle end, volume recovery, life science chemicals, margin premium + export growth (2,4-d, indoxacarb, sulphonyl urea) and liquid epoxy resin (ler) facility ramp, new capacity driving performance chemicals.

What would change the story: China remains the structural headwind, if export pricing aggression resumes (driven by domestic oversupply or policy shifts), Atul's agro-chemical and dye segments face margin re-compression similar to FY24.

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 12 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.